MARCHINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 12.626
EU - Europa 6.946
AS - Asia 4.627
SA - Sud America 484
Continente sconosciuto - Info sul continente non disponibili 357
AF - Africa 173
OC - Oceania 13
AN - Antartide 1
Totale 25.227
Nazione #
US - Stati Uniti d'America 12.159
CN - Cina 1.847
IT - Italia 1.459
SG - Singapore 1.370
RU - Federazione Russa 1.353
PL - Polonia 1.307
DE - Germania 790
GB - Regno Unito 428
BR - Brasile 393
CA - Canada 373
FR - Francia 373
VN - Vietnam 364
HK - Hong Kong 351
UA - Ucraina 339
SE - Svezia 310
FI - Finlandia 241
TR - Turchia 143
KR - Corea 135
ZA - Sudafrica 123
IN - India 105
IE - Irlanda 79
MX - Messico 49
NL - Olanda 49
BD - Bangladesh 48
JP - Giappone 39
AR - Argentina 37
BE - Belgio 36
AT - Austria 35
ES - Italia 34
PK - Pakistan 28
CZ - Repubblica Ceca 27
EU - Europa 26
IR - Iran 22
AE - Emirati Arabi Uniti 16
EG - Egitto 16
IQ - Iraq 16
RO - Romania 16
BH - Bahrain 15
EC - Ecuador 14
LT - Lituania 14
MY - Malesia 14
HN - Honduras 13
ID - Indonesia 12
UZ - Uzbekistan 12
TW - Taiwan 11
VE - Venezuela 11
AU - Australia 9
CL - Cile 9
KE - Kenya 9
JM - Giamaica 8
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
PH - Filippine 7
PT - Portogallo 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
CO - Colombia 6
MA - Marocco 6
NP - Nepal 6
RS - Serbia 6
CH - Svizzera 5
KG - Kirghizistan 5
PY - Paraguay 5
TH - Thailandia 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
DK - Danimarca 4
LV - Lettonia 4
OM - Oman 4
PE - Perù 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
HU - Ungheria 3
MD - Moldavia 3
ML - Mali 3
NZ - Nuova Zelanda 3
PA - Panama 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
BB - Barbados 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
Totale 24.876
Città #
Warsaw 1.152
Ashburn 1.020
Fairfield 992
Woodbridge 961
Jacksonville 814
Singapore 686
Houston 664
San Jose 648
Chandler 601
Ann Arbor 508
Wilmington 473
Seattle 464
Council Bluffs 462
Cambridge 356
Hong Kong 342
Boardman 332
Camerino 298
Nanjing 278
Beijing 259
Toronto 207
The Dalles 194
Los Angeles 190
New York 171
Dallas 158
Kraków 146
Dearborn 130
Seoul 128
San Mateo 126
Tongling 122
Helsinki 117
Johannesburg 113
Lauterbourg 112
Princeton 107
Lawrence 106
Columbus 101
Ho Chi Minh City 100
Istanbul 100
Nanchang 98
London 96
Ogden 94
Düsseldorf 83
Dublin 79
Moscow 77
Hanoi 75
Buffalo 73
Lachine 72
Milan 67
Chicago 64
Kunming 62
Santa Clara 61
Shanghai 59
Shenyang 57
São Paulo 51
Dong Ket 50
San Diego 48
Centro 47
Tianjin 47
Guangzhou 46
Rome 46
Hebei 45
Munich 44
Orem 44
Jinan 42
Jiaxing 41
Montreal 41
Hefei 35
St Louis 35
Tokyo 35
Brussels 34
Brooklyn 33
Denver 32
Verona 32
Falls Church 31
Phoenix 31
Changsha 30
Hangzhou 30
Zhengzhou 30
Venezia 28
Vienna 27
Redwood City 26
Trieste 25
Valle 25
Atlanta 24
Chennai 24
Ningbo 23
Bologna 22
Da Nang 22
Philadelphia 20
Athens 19
Brno 19
Wuhan 19
Mumbai 18
Redondo Beach 18
San Francisco 18
Amsterdam 17
Napoli 17
Washington 17
Avellino 16
Jinhua 16
Manchester 16
Totale 16.311
Nome #
Antioxidant and antiproliferative activities of different varieties of cauliflower (Brassica oleracea var. botrytis) after cooking processes. 492
Complessi di rutenio con attività chemioterapica antitumorale 433
Personalized liposome–protein corona in the blood of breast, gastric and pancreatic cancer patients 419
In vivo protein corona patterns of lipid nanoparticles 393
The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery 368
VirF Relieves the Transcriptional Attenuation of the Virulence Gene icsA of Shigella flexneri Affecting the icsA mRNA-RnaG Complex Formation 344
The water soluble ruthenium(II) organometallic compound[Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Clsuppresses triple negative breast cancer growth by inhibiting tumorinfiltration of regulatory T cells 334
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition 332
Resveratrol fuels HER2 and ERα‐positive breast cancer behaving as proteasome inhibitor 330
Aspirin modulates LPS-induced nitric oxide release in rat glial cells 324
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 324
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 293
Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer 289
Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells 287
A novel 39-tRNAGlu-derived fragment acts as a tumor-suppressor in breast cancer by targeting nucleolin 276
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 272
Tailoring DNA vaccines: designing strategies against HER2-positive cancers 271
Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD) 269
HER2-Driven carcinogenesis: new mouse models for novel immunotherapies 266
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. 266
Cholesterol dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO Living Cells 264
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 263
Tumor vessel compression hinders perfusion of ultrasonographic contrast agents 260
Azolate/phosphane Gold(I) compounds in antiproliferative therapy: a new frontier for the azolate gold(I) chemistry 260
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer 258
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2- positive breast carcinomas resistant to Lapatinib 257
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling 256
Combination of Coenzyme Q10 intake and moderate physical activity counteracts mitochondrial dysfunctions in a SAMP8 mouse model Oxidative Medicine and Cellular Longevity. 256
NANOPARTICELLE LIPIDICHE MULTICOMPONENTI E PROCEDIMENTI PER LA LORO PREPARAZIONE 249
Azolate gold(I) phosphane complexes as innovative therapies for the treatment of HER2-driven breast cancer 245
Cyclooxygenase-2 (COX2) gene silencing with siRNA could enhance DNA vaccination to inhibit established ErbB-2 carcinomas 242
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells 241
Factors Determining the Superior Performance of Lipid/DNA/Protammine Nanoparticles over Lipoplexes. 241
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 240
Structure-function relationships in bovine thymus 20S proteasome: a fluorimetric study 239
IN VITRO AND IN VIVO STUDIES FOR THE TREATMENT OF BASAL LIKE BREAST CANCER (BLBC) WITH AZOLATE/PHOSPHANE GOLD(I) COMPOUNDS 237
Getting the most from gene delivery by repeated DNA transfections 237
Role of temperature-independent lipoplex-cell membrane interactions in the efficiency boost of multicomponent lipoplexes. 233
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 230
Characterization of an inwardly rectifying chloride conductance expressed by cultured rat cortical astrocytes. 226
Tailoring lipoplex composition to the lipid composition of plasma membrane: a Trojan horse for cell entry? 225
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients 225
Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition 223
Vaccination trials against bovine herpesvirus-1 220
Toward the Rational Design of Lipid Gene Vectors: Shape Coupling between Lipoplex and Anionic Cellular Lipids Controls the Phase Evolution of Lipoplexes and the Efficiency of DNA Release 216
Ruthenium Complexes with Antitumoral Chemiotherapy Activites 214
Antiproliferative Activity of a New (Arene)Ruthenium(II) Complex on a Model of Breast Cancer 213
Transfection efficiency boost by designer multicomponent lipoplexes 211
Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells 211
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 209
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 208
Transfection efficiency boost of cholesterol-containing lipoplexes 207
Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density 204
Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules 204
Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity 202
Homeostatic effects of adenosine on potentially neurotoxic glial cell activation. 197
LIBRERIA FAGICA DI FRAMMENTI DELLA PROTEINA HER2 197
Protective mechanisms of adenosine in neurons and glial cells. 197
Novel Mechanisms of Cell Uptake in Lipid-Mediated Gene Delivery 196
Costrutto di acido nucleico, vettore e vaccino a DNA includenti detto costrutto 196
On the correlation between phase evolution of lipoplexes/anionic lipid mixtures and DNA release 195
DNA release from cationic liposome/DNA complexes by anionic lipids 195
Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes 193
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 192
p185neu encoding DNA and therapeuticaluses thereof 192
P185neu-encoding DNA and therapeutical uses thereof 191
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 190
Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination 190
Surface adsorption of protein corona controls the cell uptake mechanism in efficient cationic liposome/DNA complexes in serum. 188
Cascading glial reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. 187
The Second Ascoli Piceno Conference on Gene Vacciantion in Cancer, October 9-11 2013 186
Two distinct inwardly rectifying conductances are expressed in long term dibutyryl-cyclic-AMP treated rat cultured cortical astrocytes. 184
Characterization of two voltage-dependent, inwardly rectifying currents in dibutyryl-cyclic AMP treated cortical astrocytes 183
Cationic lipid/DNA complexes manufactured by microfluidics and bulk self-assembly exhibit different transfection behavior 183
Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A 181
Mechanistic Understanding of Gene Delivery Mediated by Highly Efficient Multicomponent Envelope-Type Nanoparticle Systems 181
Surface area of lipid membranes regulates the DNA-binding capacity of cationic liposomes. 180
Effects of a supplementation with tart cherry (Prunus cerasus L.) juice and its kernel extract on antioxidant status and muscle health 177
Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. 173
Effect of pH on the structure of lipoplexes 172
Glia-related pathomechanisms in Alzheimer' s disease: a therapeutic target? 172
Self-assembled ternary complexes of neutral liposomes, DNA and bivalent metal cations. Promising vectors for gene transfer? 170
Efficient Delivery of DNA Using Lipid Nanoparticles 169
Programmed packaging of multicomponent envelope-type nanoparticle system for gene delivery. 169
Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes 167
p185neu-Encoding DNA and therapeutical uses thereof 165
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 165
DNA codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici 164
DNA codificante p185neu e suoi usi terapeutici 162
Programmed packaging of multicomponent envelope-type nanoparticle system (MENS). 160
Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth 157
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favors early tumor growth in syngeneic mice. 157
Mesenchymal/stromal gene expression signature relates to Basal-like breast cancers, identify bone metastasis and predicts resistance to therapies. 156
Stathmin is required for normal mouse mammary gland development and Δ16HER2-driven tumorigenesis 154
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 153
Structural stability against disintegration by anionic lipids rationalizes the efficency of cationic liposom/DNA complexes 151
A Study of Bioactivities and Composition of a Cocktail of Supernatants Derived from Lactic Acid Bacteria for Potential Food Applications 150
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 147
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 146
Role of cholesterol on the transfection barriers of cationic lipid/DNA complexes 135
Totale 22.573
Categoria #
all - tutte 97.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.272 0 314 37 60 95 84 52 96 128 117 154 135
2022/20231.653 172 43 88 214 171 239 10 140 300 103 124 49
2023/20241.224 158 75 82 42 55 138 46 40 139 41 26 382
2024/20253.941 145 69 292 153 133 184 520 1.019 318 300 225 583
2025/20265.664 407 339 432 810 616 441 968 442 240 411 369 189
2026/2027546 366 180 0 0 0 0 0 0 0 0 0 0
Totale 25.227